The development of prostaglandins

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 17, Issue 5, 2003, Pages 703-706

  Baskett, Thomas F ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Historical development; Prostaglandins; Reproduction

Indexed keywords

CARBOPROST; GEMEPROST; MISOPROSTOL; OXYTOCIC AGENT; OXYTOCIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE INHIBITOR; SULPROSTONE;

ABORTION; CLINICAL PRACTICE; DOSE RESPONSE; DRUG ABSORPTION; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG USE; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HUMAN; LABOR INDUCTION; OBSTETRICS; PEPTIC ULCER; PREGNANCY; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REVIEW;

EID: 0141830272     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6934(03)00048-8     Document Type: Review

References (36)

1. Harley GW (ed.) Native African Medicine with Special Reference to Its Practice in the Mano Tribe of Liberia. London: Frank Cass and Co Ltd, 1970, pp 237.
2. Jappelli G & Scaffa GM. On the effects of intravenous injection of dog prostate extract. Archivio Italiano di Biologia 1906; 45: 165-180.
3. Kurzrok R & Lieb CC. Biochemical studies on human semen. II. Action of semen on human uterus. Proceedings: Experimental Biology and Medicine (NY) 1930; 28: 268-272.
4. Cockrill JR, Maller EG & Kurzrok R. The substance in human seminal fluid affecting uterine muscle. American Journal of Physiology 1935; 122: 577-580.
5. Goldblatt MW. A depressor substance in seminal fluid. Journal of the Society of Chemistry and Industry 1933; 52: 1056-1057.
6. Goldblatt MW. Properties of human seminal plasma. Journal of Physiology 1933; 84: 208-218.
7. Von Euler US. An adrenal-like action in extracts from prostatic and related glands. Journal of Physiology 1934; 81: 102-112.
8. Von Euler US. A depressor substance in the vesicular gland. Journal of Physiology 1935; 84: 21.
9. Von Euler US. Wenn die spezifische Blutdnucksenkeude Substanz des Menschlichen Prostate und Samenbläschenscketes. Klinische Wochenschrift 1935; 14: 1182-1186.
10. Von Euler US. On the specific vaso-dilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin). Journal of Physiology 1936; 88: 213-214.
11. Bergstrom S & Sjovall J. The isolation of prostaglandin F from sheep prostate glands. Acta Chemica Scandinavica 1960; 14: 1693-1700.
12. Bergstrom S & Sjovall J. The isolation of prostaglandin E from sheep prostate glands. Acta Chemica Scandinavica 1960; 14: 1701-1705.
13. Bergstrom S, Ryhage R, Samuelsson B & Sjovall J. The structure of prostaglandin E, F1 and F2. Acta Chemica Scandinavica 1962; 16: 501-502.
14. Bergstrom S, Ryhage R, Samuelsson B & Sjovall J. Prostaglandins and related factors 15. The structures of prostaglandin E1α and F1β. Journal of Biological Chemistry 1963; 238: 3555-3564.
15. Von Euler US. Pieces in the puzzle. Annual Review of Pharmacology 1971; 11: 1-12.
16. Sparkes RM (ed.) Prostaglandin Abstracts: A Guide to the Literature, 1. New York: IFI/Plenum, 1974. 1906-1970.
17. Shalita RA (ed.) Prostaglandin Abstracts: A Guide to the Literature, 11. New York: IFI/Plenum, 1975. 1971-1973.
18. Karim SMM, Trussell RR, Hillier K & Patel RC. Induction of labour with prostaglandin F2 alpha. British Medical Journal 1968: 4: 621-623.
19. Bygdeman M, Kwon SU, Murkergee T & Wiqvist N. Effects of intravenous infusion of prostaglandin E1 and E2 on motility of the pregnant human uterus. American Journal of Obstetrics and Gynecology 1968; 106: 567-572.
20. Nelson GH. Prostaglandins and reproduction. Current Problems in Obstetrics and Gynecology 1980; 4: 1-33.
21. Karim SMM & Filschie GM. Therapeutic abortion using prostaglandin F2 alpha. Lancet 1970; 1: 157.
22. Wiqvist N, Bygdeman M & Toppozada M. Induction of abortion by intravenous administration of prostaglandin F2. Acta Obstetrica et Gynaecologica Scandinavica 1971; 50: 381-384.
23. Southern EM. Prostaglandins: Clinical Application in Human Reproduction. New York: Futura Publishing Co, 1972.
24. Karim SMM, Sharma SD & Filschie GM. Termination of pregnancy with 15-methyl analogues of prostaglandins E2 and F2. Journal of Reproductive Medicine 1972; 9: 383-385.
25. Cameron IT, Michie AF & Baird DT. Prostaglandin-induced pregnancy termination: Further studies using gemeprost vaginal pessaries in the early second trimester. Prostaglandins 1987; 34: 111-117.
26. WHO Prostaglandin Task Force, Termination of second trimester pregnancy by intramuscular injection of 16-pheonoxy-(i)17,18,19-tetranar PGE2 methyl sulfonylamide. International Journal of Gynaecology and Obstetrics 1982; 20: 383-386.
27. Collins PW. Misoprostol: Discovery, development and clinical applications. Medicinal Research Reviews 1990; 10: 149-172.
28. Editorial, Misoprostol and legal medical abortion. Lancet 1991; 338: 1241-1242.
29. Takagi S, Yoshida T, Togo Y et al. The effects of intramyometrial injections of prostaglandin F2α on severe postpartum hemorrhage. Prostaglandins 1976; 12: 565.
30. Corson SL & Bolognese RJ. Postpartum uterine atony treated with prostaglandins. American Journal of Obstetrics and Gynecology 1977; 129: 918-921.
31. Hayashi RH, Castillo MS & Noah ML. Management of severe postpartum hemorrhage due to uterine atony using an analogue of prostaglandin F2 alpha. Obstetrics and Gynecology 1981; 58: 426-429.
32. Annathasubramnim L, Kuntal R, Sivariamin R & Ragahvan KS. Management of intractable postpartum haemorrhage secondary to uterine atony with intramuscular 15-methyl PGF2α. Acta Obstetrica et Gynaecologica Scandinavica 1988; 145(supplement): 17-19.
33. Baskett TF. A flux of the reds: Evolution of active management of the third stage of labour. Journal of the Royal Society of Medicine 2000; 93: 489-493.
34. El-Rafaey H, O'Brien P, Morafa W et al. Use of oral misoprostol in the prevention of postpartum haemorrhage. British Journal of Obstetrics and Gynaecology 1997; 104: 36-39.
35. O'Brien P, El-Rafaey H, Gordon A et al. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: A descriptive study. Obstetrics and Gynecology 1998; 92: 212-214.
36. Bamigboye AA, Hofmeyr GJ & Merrell DA. Rectal misoprostol in the prevention of postpartum hemorrhage: A placebo-controlled trial. American Journal of Obstetrics and Gynecology 1998; 179: 1043-1046.